Community pharmacies in England dispense 174 million more prescription items annually than in 2010, a figure that is predicted to rise further. Despite this, total funding for the community pharmacy contract is heading back towards 2010 levels.
Reclassifying emergency hormonal contraception levonorgestrel from a pharmacy to general sale medicine is not the answerSubscription
Instead of making levonorgestrel available to purchase in any retail outlet without medical advice, it would be better to improve emergency hormonal contraception consultations, lower the price of the medicine and make it more easily accessible via national patient group directions.
In our review of 2016, The Pharmaceutical Journal highlights the people behind the biggest pharmacy stories of the past 12 months. These are men and women who we considered to be the most strongly connected with the news stories that had the biggest impact on our readers.
Acting on the potential of action potentials: will bioelectronic medicines be the next biologics?Subscription
Bioelectronic medicine is a new approach to treating major chronic diseases that could give doctors and patients alternatives to costly mainstream medicine and may become as commonly prescribed as chemical or biological drugs. Some researchers and pharmaceutical companies are already taking this potential new class of treatments seriously and, as promising results emerge, others are expected to follow.
It’s been a long time coming, but a new class of drugs targeting the CGRP protein could be the first preventative treatment specifically developed for migraine to hit the market.
William Seligman takes a look at what might happen to the US healthcare system and pharma under a Trump presidency.
Q&A: World Bank warns that inaction on antimicrobial resistance could increase healthcare costs in developing countriesSubscription
Tim Evans from the World Bank Group talks about new research that shows how inaction on antimicrobial resistance could wipe out decades of healthcare gains and dramatically increase healthcare costs in developing countries.
Highlights of CPD and learning in 2016Subscription
Try our clinical quiz, with questions taken from this year’s learning and CPD articles, and check your knowledge of subjects ranging from antimicrobial therapy to bipolar disorder.
A basic introduction to statisticsSubscription
Pharmacists and healthcare professionals involved in research and report writing should have an understanding of basic statistical methods that can be applied to study data and used in reporting research results.
How your hobbies can boost your careerSubscription
Steve Hemsley investigates the interesting hobbies of pharmacists and how the skills they gain translate into career skills.
Oncology pharmacist Davina Lau describes the intensity of working with patients who are having treatment for cancer.
As a professional rugby player and pharmacist, Ross Wardle fields questions from his colleagues about doping and is concerned about long-term health problems associated with the sport.
Pharmacist Adam Grainger’s first arrest has so far been his most exciting moment as a special constable.
The UK competition watchdog has fined two pharmaceutical companies £90m for charging what it has called excessive and unfair prices in the UK for phenytoin capsules.
NHS England has announced it will fund a large-scale clinical trial on the use of pre-exposure prophylaxis (PrEP) for the prevention of HIV ahead of a national roll-out.
New guideline recommends that HIV testing should be available in community settings, the voluntary sector and venues where there may be high-risk sexual behaviour.
The Pharmaceutical Services Negotiating Committee has applied to the High Court for a judicial review of the decision to implement cuts to community pharmacy funding in England on the grounds that it believes the secretary of state failed to carry out a lawful consultation.
Ellipta inhaler device comes out on top in GSK-sponsored research comparing several types of inhaler devices and their misuse among COPD and asthma patients.
Emergency hormonal contraception should be available to buy from non-pharmacy retail outlets in the UK, urges the British Pregnancy Advisory Service, a reproductive health services charity.
News in Brief
A landmark US law that would boost funding for medical research, mental health and substance misuse services and speed up drug and medical device approval has passed its latest legislative hurdle.
Scientists have mapped all 1,578 drugs licensed by the US Food and Drug Administration according to their mechanisms of action to help researchers visualise the ‘uncharted waters’ where they may find future treatments.
RPS 'delighted' with proposed changes to supervision of pharmacists training to be prescribersSubscription
Sandra Gidley, chair of the RPS English Pharmacy Board, says the RPS is surprised and delighted to see the GPhC consultation document proposing changes to the supervision of pharmacists training to be prescribers
NHS England has published details of a new service that will see patients referred by NHS 111 to community pharmacies for urgent repeat medicines.
A clinical trial testing a new immunotherapy to treat cancer, which was stopped in July 2016 after three patients died and was restarted again, has been suspended for the second time following another death.
Around 1 in 55 hospital admissions may have been caused by an adverse event triggered by a reaction between a dietary or herbal supplement and another medicine or supplement, according to Israeli research.
A lack of awareness about reporting systems for adverse drug reactions (ADRs) and confusion about how they work are preventing patients from informing medicines safety regulators when something goes wrong, according to research published in the British Journal of Clinical Pharmacology
NHS spending on drugs in England increased by 8% to £16.8bn in 2015–2016 from £15.5bn in 2014–2015, which was largely driven by spending on medicines by hospitals, a report by NHS Digital shows.
There was no new money for the NHS or social care announced in the autumn statement on 23 November 2016, despite warnings from the NHS and local government that services are at breaking point and evidence that a crisis in social services is heightening pressure on an already overburdened NHS.